Studies on intestinal inflammation diseases targeted the protein that functions to prevent bacterium attack and revealed the mechanism that they work to achieve the protection, which may lay a foundation for the design and development of new drugs for ulcerative colitis.

Researchers made use of the mice that were induced with colitis by the application of dextran sulfate sodium (DSS), and during the process it was found that lower level of the protein-Lypd8 connected with more serious colitis condition compared within group and with healthy mice. With further probing, the protein was locked as the substance playing a significant role in protecting the body from being invaded by the bacteria.

After the recognition, deeper studies to inspect how the protein works to stop the bacterial invading were conducted and the mechanism revealed. The protein presents in the form of strings and by attaching to the body of bacteria to obstacle the activities of its carrier.

But exactly how the protein inhibit the bacteria’s invading is yet to be researched. With the present known general knowledge, it’s possible to apply the innovation to the future drugs.